United Therapeutics reported 19.41 in PE Price to Earnings for its fiscal quarter ending in September of 2026.





Pe Change Date
Amarin 91.05 88.3 Jun/2023
Baxter International 20.35 131.6 Sep/2026
Bayer 4.61 0.47 Sep/2026
BioCryst Pharmaceuticals 6.84 0.78 Jun/2026
Biogen 29.15 5.92 Sep/2026
BioMarin Pharmaceutical 53.62 32.55 Sep/2026
Emergent BioSolutions 14.4 2.25 Sep/2022
Gilead Sciences 17.68 4.18 Sep/2026
GlaxoSmithKline 9.72 0.9 Sep/2026
Halozyme Therapeutics 16.12 3.61 Sep/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
J&J 25.86 3.57 Sep/2026
Lexicon Pharmaceuticals 12.44 4.73 Jun/2021
Moderna 27.22 14.51 Jun/2023
Pfizer 15.2 3.72 Sep/2026
PTC Therapeutics 8.76 0 Jun/2026
Regeneron Pharmaceuticals 15.46 9.68 Jun/2026
Sarepta Therapeutics 32.09 22.66 Sep/2026
Teva Pharmaceutical Industries 18.7 5.9 Sep/2026
United Therapeutics 19.41 0.26 Sep/2026
Vertex Pharmaceuticals 29.35 1.3 Sep/2026